Irritant contact dermatitis (ICD) affects up to 90% of children and adolescents using insulin pumps and continuous glucose monitors (CGMs). It is painful, persistent, and reduces the number of viable skin sites for device placement. The result is a frustrating cycle for both families and healthcare professionals.
SensiPatch is a thin, occlusive hydrocolloid patch developed to support the skin’s natural healing process. It is free from steroids, easy to apply, and creates a moist wound environment that promotes faster healing of irritated skin.
Hydrocolloid is a skin-friendly, moisture-retaining material widely used in modern wound care. It forms a gel when in contact with skin exudate, creating optimal conditions for healing – without drying out or irritating the skin.
An independent study conducted by Steno Diabetes Center Copenhagen and Herlev Hospital (Berg et al., 2023) demonstrated that:
Faster healing means a quicker return to treatment, less discomfort, and reduced need for steroid creams, which is especially important in pediatric care.
While steroid creams can be effective for short-term use, prolonged application – especially in children – may lead to side effects such as skin thinning and increased sensitivity. That’s why steroid-free options are an important alternative in managing skin reactions.
SensiPatch helps families break the cycle of repeated skin damage and provides healthcare professionals with a safe, simple tool to support skin health.
The study was published in Diabetes Technology & Therapeutics and presented as a late-breaking abstract at ATTD 2023.
A heartfelt thank you to the incredible families, clinicians, and researchers who made this study possible ❤️
